RecruitingPhase 3NCT07087054
Oncology
Carcinoid syndrome
2
studies recruiting now
as of 7 Sept 2026
70
studies registered in total
as of 7 Sept 2026
13
countries with a recruiting site
as of 7 Sept 2026
25 Jul 2025
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 2NCT05969860
At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
Showing the 2 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
Search all Carcinoid syndrome studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Carcinoid syndrome study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Carcinoid syndrome
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the gene involved (SDHD).
Treatments being studied
2 approved treatments and 6 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Approved: Telotristat Ethyl (Xermelo)Approved: Lanreotide Acetate (Somatuline depot)
Phase 3Telotristat
Phase 3Surotomycin (Cb-183, 315)
Phase 3Lanreotide (Somatuline autogel)
Phase 2Onzigolide
Phase 2Panitumumab (Vectibix)
Phase 2Octreotide
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).